Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement

Neuroscience and Biobehavioral Reviews

Volumn 31, Issue 6, 2007, Pages 825-831

  Gould, Todd D ^a   Einat, Haim ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Animal model; Antidepressants; Antipsychotics; Depression; Lithium; Manic depressive illness; Mouse; Rat; Valproic acid

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER;

BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG EFFICACY; GENE ACTIVITY; GENE IDENTIFICATION; GENETICS; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYMPTOM; VALIDITY;

ANIMALS; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; PHENOTYPE; PSYCHOTROPIC DRUGS;

EID: 34548040641     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.05.007     Document Type: Review

References (67)

1. Akil H. Stressed and depressed. Nature Medicine 11 (2005) 116-118
2. Angst J., Gamma A., Benazzi F., Ajdacic V., Eich D., and Rossler W. Diagnostic issues in bipolar disorder. European Neuropsychopharmacology 13 Suppl. 2 (2003) S43-S50
3. Antelman S.M., Caggiula A.R., Kucinski B.J., Fowler H., Gershon S., Edwards D.J., Austin M.C., Stiller R., Kiss S., and Kocan D. The effects of lithium on a potential cycling model of bipolar disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 22 (1998) 495-510
4. Antelman S.M., Caggiula A.R., Edwards D.J., Gershon S., Kucinski B.J., Kiss S., and Kocan D. Long-term oscillation of corticosterone following intermittent cocaine. Journal of Neural Transmission 107 (2000) 369-375
5. Begley C.E., Annegers J.F., Swann A.C., Lewis C., Coan S., Schnapp W.B., and Bryant-Comstock L. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 19 (2001) 483-495
6. Belmaker, R.H., Bersudsky, Y., 2007. Lithium-pilocarpine seizures as a model for lithium action in mania. Neuroscience and Biobehavioral Reviews, in press, doi:10.1016/j.neubiorev.2007.05.001.
7. Bourin, M., Corina, P., 2007. The role of mood stabilizers in the treatment of depressive facets of bipolar disorders. Neuroscience and Biobehavioral Reviews, doi:10.1016/j.neubiorev.2007.03.001.
8. Caggiula A.R., Antelman S.M., Kucinski B.J., Fowler H., Edwards D.J., Austin M.C., Gershon S., and Stiller R. Oscillatory-sensitization model of repeated drug exposure: cocaine's effects on shock-induced hypoalgesia. Progress in Neuropsychopharmacology and Biological Psychiatry 22 (1998) 511-521
9. Calabrese J.R., Hirschfeld R.M., Reed M., Davies M.A., Frye M.A., Keck P.E., Lewis L., McElroy S.L., McNulty J.P., and Wagner K.D. Impact of bipolar disorder on a US community sample. The Journal of Clinical Psychiatry 64 (2003) 425-432
10. Chuang D.M. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?. Critical Reviews in Neurobiology 16 (2004) 83-90
11. Cryan J.F., and Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nature Reviews in Drug Discovery 4 (2005) 775-790
12. Cryan J.F., and Slattery D.A. Animal models of mood disorders: recent developments. Current Opinion in Psychiatry 20 (2007) 1-7
13. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
14. Einat H. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behavior Genetics 37 (2006) 244-255
15. Einat H. Modelling facets of mania-new directions related to the notion of endophenotypes. Journal of Psychopharmacology 20 (2006) 714-722
16. Einat, H., 2007. Different behaviors and different strains: potential new ways to model bipolar disorder. Neuroscience Biobehaviorial Reviews, doi:10.1016/j.neubiorev.2006.12.001.
17. Einat H., and Manji H.K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biological Psychiatry 59 (2006) 1160-1171
18. Einat H., and Szechtman H. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Physiology and Behaviour 57 (1995) 55-59
19. El-Mallakh R.S., Harrison L.T., Li R., Changaris D.G., and Levy R.S. An animal model for mania: preliminary results. Progress in Neuropsychopharmacology and Biological Psychiatry 19 (1995) 955-962
20. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., Nemeroff C.B., Bremner J.D., Carney R.M., Coyne J.C., Delong M.R., Frasure-Smith N., Glassman A.H., Gold P.W., Grant I., Gwyther L., Ironson G., Johnson R.L., Kanner A.M., Katon W.J., Kaufmann P.G., Keefe F.J., Ketter T., Laughren T.P., Leserman J., Lyketsos C.G., McDonald W.M., McEwen B.S., Miller A.H., Musselman D., O'Connor C., Petitto J.M., Pollock B.G., Robinson R.G., Roose S.P., Rowland J., Sheline Y., Sheps D.S., Simon G., Spiegel D., Stunkard A., Sunderland T., Tibbits Jr. P., and Valvo W.J. Mood disorders in the medically ill: scientific review and recommendations. Biological Psychiatry 58 (2005) 175-189
21. Fiorino D.F., and Phillips A.G. Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 142 (1999) 200-208
22. Glahn D.C., Bearden C.E., Niendam T.A., and Escamilla M.A. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disorders 6 (2004) 171-182
23. Goodwin F.K., and Jamison K.R. Manic-Depressive Illness (1990), Oxford University Press, New York
24. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160 (2003) 636-645
25. Gould T.D., and Gottesman I.I. Psychiatric endophenotypes and the development of valid animal models. Genes, Brain and Behaviour 5 (2006) 113-119
26. Gould T.D., and Manji H.K. The molecular medicine revolution and psychiatry: bridging the gap between basic neuroscience research and clinical psychiatry. Journal of Clinical Psychiatry 65 (2004) 598-604
27. Gould T.D., Gray N.A., and Manji H.K. The cellular neurobiology of severe mood and anxiety disorders: implications for the development of novel therapeutics. In: Charney D.S. (Ed). Molecular Neurobiology for the Clinician (2003), American Psychiatric Press, Inc., Washington 123-227
28. Gould T.D., Quiroz J.A., Singh J., Zarate C.A., and Manji H.K. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Molecular Psychiatry 9 (2004) 734-755
29. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., and Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 23 (2003) 6690-6694
30. Hasler G., Drevets W.C., Manji H.K., and Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 29 (2004) 1765-1781
31. Hasler G., Drevets W.C., Gould T.D., Gottesman Jr., and Manji H.K. Toward constructing an endophenotype strategy for bipolar disorders. Biological Psychiatry 60 (2006) 93-105
32. Herman, L., Hougland, T., El-Mallakh, R.S., 2007. Mimicking human bipolar ion dysregulation models mania in rats. Neuroscience Biobehavioural Reviews, in press, doi:10.1016/j.neubiorev.2007.04.001.
33. Kasahara T., Kubota M., Miyauchi T., Noda Y., Mouri A., Nabeshima T., and Kato T. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Molecular Psychiatry 11 (2006) 577-593 523
34. Kato, T., Kubota, M., Kasahara, T., 2007. Animal models of bipolar disorder. Neuroscience Biobehavioural Reviews, doi:10.1016/j.neubiorev.2007.03.003.
35. Kleinman L., Lowin A., Flood E., Gandhi G., Edgell E., and Revicki D. Costs of bipolar disorder. Pharmacoeconomics 21 (2003) 601-622
36. Kupfer D.J. The increasing medical burden in bipolar disorder. JAMA 293 (2005) 2528-2530
37. Le-Niculescu, H., McFarland, M.J., Mamidipalli, S., Ogden, C.A., Kuczenski, R., Kurian, S.M., Salomon, D.R., Tsuang, M.T., Nurnberger Jr., J.I., Niculescu 3rd., A.B., 2007. Convergent functional genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers. Neuroscience Biobehavioural Reviews, in press, doi:10.1016/j.neubiorev.2007.05.008.
38. Lenox R.H., Gould T.D., and Manji H.K. Endophenotypes in bipolar disorder. American Journal of Medical Genetics 114 (2002) 391-406
39. Lu B. BDNF and activity-dependent synaptic modulation. Learning and Memory 10 (2003) 86-98
40. Malatynska E., and Knapp R.J. Dominant-submissive behavior as models of mania and depression. Neuroscience Biobehavioural Reviews 29 (2005) 715-737
41. Malatynska, E., Pinhasov, A., Creighton, C.J., Crooke, J.J., Reitz, A.B., Brenneman, D.E., Lubomirski, M.S., 2008. Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationships. Neuroscience Biobehavioural Reviews, in press, doi:10.1016/j.neubiorev.2007.05.004.
42. Manji H.K., Moore G.J., and Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?. Biological Psychiatry 46 (1999) 929-940
43. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K.N.A.G., Zarate Jr. C.A., and Charney D.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biological Psychiatry 53 (2003) 707-742
44. McClung C.A. Circadian genes, rhythms and the biology of mood disorders. Pharmacology and Therapeutics 114 (2007) 222-232
45. McDonald C., Bullmore E.T., Sham P.C., Chitnis X., Wickham H., Bramon E., and Murray R.M. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Archives of General Psychiatry 61 (2004) 974-984
46. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E.D.H.M., Petukhova M., and Kessler R.C. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Archives of General Psychiatry 64 (2007) 543-552
47. Michaud C.M., Murray C.J., and Bloom B.R. Burden of disease-implications for future research. JAMA 285 (2001) 535-539
48. Morozov A., Kellendonk C., Simpson E., and Tronche F. Using conditional mutagenesis to study the brain. Biological Psychiatry 54 (2003) 1125-1133
49. Nestler E.J., Gould E., Manji H.K., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., Robbins T., Winsky L., and Zalcman S. Preclinical models: status of basic research in depression. Biological Psychiatry 52 (2002) 503-528
50. O'Brien W.T., Harper A.D., Jove F., Woodgett J.R., Maretto S., Piccolo S., and Klein P.S. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. Journal of Neuroscience 24 (2004) 6791-6798
51. O'Donnell, K.C., Gould, T.D., 2007. The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neuroscience Biobehavioural Reviews, in press, doi:10.1016/j.neubiorev.2007.04.002.
52. Papp M., Willner P., and Muscat R. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacology (Berlin) 110 (1993) 159-164
53. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., and Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience 24 (2004) 10099-10102
54. Post R.M. Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sciences 26 (1980) 1275-1282
55. Post, R.M., 2007. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neuroscience Biobehavioural Reviews, in press, doi:10.1016/j.neubiorev.2007.04.003.
56. Post R.M., Uhde T.W., Putnam F.W., Ballenger J.C., and Berrettini W.H. Kindling and carbamazepine in affective illness. Journal of Nervous and Mental Diseases 170 (1982) 717-731
57. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Research 396 (1986) 157-198
58. Rowe, M.K., Wiest, C., Chuang, D.M., 2007. GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neuroscience Biobehavioural Reviews, in press, doi:10.1016/j.neubiorev.2007.03.002.
59. Roybal K., Theobold D., Graham A., Dinieri J.A., Russo S.J., Krishnan V., Chakravarty S., Peevey J., Oehrlein N., Birnbaum S., Vitaterna M.H., Orsulak P., Takahashi J.S., Nestler E.J., Carlezon Jr. W.A., and McClung C.A. From the cover: mania-like behavior induced by disruption of CLOCK. Proceedings of the National Academy of Sciences USA 104 (2007) 6406-6411
60. Rybakowski J.K., Borkowska A., Skibinska M., and Hauser J. Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Molecular Psychiatry 11 (2006) 122-124
61. Seong E., Seasholtz A.F., and Burmeister M. Mouse models for psychiatric disorders. Trends in Genetics: TIG 18 (2002) 643-650
62. Stewart J.J., and Badiani A.A. Tolerance and sensitization to the behavioral effects of drugs. Behavioural Pharmacology 4 (1993) 289-312
63. Valtonen H., Suominen K., Mantere O., Leppamaki S., Arvilommi P., and Isometsa E.T. Suicidal ideation and attempts in bipolar I and II disorders. Journal of Clinical Psychiatry 66 (2005) 1456-1462
64. Woods S.W. The economic burden of bipolar disease. Journal of Clinical Psychiatry 61 Supp 13 (2000) 38-41
65. Young, J.W., Minassian, A., Paulus, M.P., Geyer, M.A., Perry, W., 2007. A reverse-translational approach to bipolar disorder: rodent and human studies in the behavioral pattern monitor. Neuroscience Biobehavioural Reviews, in press, doi:10.1016/j.neubiorev.2007.05.009.
66. Young R.C. Bipolar disorder in older persons: perspectives and new findings. American Journal of Geriatric Psychiatry 13 (2005) 265-267
67. Youngstrom E.A., Findling R.L., Youngstrom J.K., and Calabrese J.R. Toward an evidence-based assessment of pediatric bipolar disorder. Journal of Clinical Child and Adolescent Psychology 34 (2005) 433-448